Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Comparison of turbinate volume reduction surgeries for nasal symptoms and surgery-related adverse effects in patients with chronic rhinitis: a systematic review and network meta-analysis
Kim, D. H., Jang, D. W. & Hwang, S. H., Mar 2026, In: European Archives of Oto-Rhino-Laryngology. 283, 3, p. 1443-1454 12 p.Research output: Contribution to journal › Review article › peer-review
-
Effects of Sphenopalatine Ganglion Nerve Block on Bleeding and Pain During and After Septorhinoplasty: A Systemic Review and Meta-analysis
Kim, D. H., Jang, D. W. & Hwang, S. H., Feb 2026, In: Aesthetic Plastic Surgery. 50, 3, p. 955-965 11 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
Invited Response on: “Letter on Effects of Sphenopalatine Ganglion Nerve Block on Bleeding and Pain During and After Septorhinoplasty: A Systemic Review and Meta-analysis”
Kim, D. H., Jang, D. W. & Hwang, S. H., Feb 2026, In: Aesthetic Plastic Surgery. 50, 3, p. 968 1 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
The Effects of Pain Controlling Agents on Paediatric Tonsillectomy: A Systematic Review and Network Meta-Analysis
Kim, D. H., Jang, D. W. & Hwang, S. H., Mar 2026, In: Clinical Otolaryngology. 51, 2, p. 222-232 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Bleeding potential and effectiveness of perioperative ketorolac administration in tonsillectomy: A systemic review and meta-analysis
Kim, D. H., Jang, D. W. & Hwang, S. H., Nov 2025, In: International Journal of Pediatric Otorhinolaryngology. 198, 112608.Research output: Contribution to journal › Review article › peer-review
Press/Media
-
Monthly: Vivos Therapeutics (VVOS: $2.85) continues significant downtrend; tumbles 18%
1/04/25
1 item of Media coverage
Press/Media
-
Weekly: Vivos Therapeutics (VVOS: $3.11) plunges 14% on feeble volume; -49c [13.6%]
29/03/25
1 item of Media coverage
Press/Media
-
Weekly: Vivos Therapeutics (VVOS: $3.60) jumps 9% - outperforming 83% of stocks; +30c [9.1%]
22/03/25
1 item of Media coverage
Press/Media
-
Weekly: Vivos Therapeutics (VVOS: $3.30) tumbles 11% on feeble volume; -39c [10.6%]
15/03/25
1 item of Media coverage
Press/Media
-